Neuronetics (STIM) stock: insider trades, news & valuation
Health Care · Net buyingShare price and insider trades
Neuronetics insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $4.8M and 3 sold $282K of STIM stock on the open market.
Get emailed when insiders cluster-buy stocks like STIM
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
STIM insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | $107K | 2 | — | 0 |
| Q2 2026 | $1.1M | 4 | — | 0 |
| Q1 2026 | $3.6M | 8 | $282K | 11 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 Neuronetics, Inc. insider reported open-market purchases totaling $4.8M, while 3 insiders reported sales totaling $282K. Among insiders with enough purchase history to measure, Jorey Chernett (10% Owner) has the highest Insider Score at 100. 0 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
STIM stock news and SEC filings
Recent 8-K filings and headlines. Tone is scored from the headline wording; “Policy” marks regulatory, trade or government topics.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Aug 17SEC | Jorey Chernett10% Owner | Buy | 14,00010,602,988 held (+0%) | $3.16 | $44K | -32.6% | 100 |
| Jul 15SEC | Jorey Chernett10% Owner | Buy | 35,00010,588,988 held (+0%) | $1.78 | $62K | +19.7% | 100 |
| May 21SEC | Steven PfanstielCFO | Sell | 8,569836,643 held (−1%) | $1.34 | $11K | +59.0% | — |
| May 20SEC | Jorey Chernett10% Owner | Buy | 100,00010,553,988 held (+1%) | $1.17 | $117K | +82.1% | 100 |
| May 13SEC | Jorey Chernett10% Owner | Buy | 475,00010,453,988 held (+5%) | $1.34 | $636K | +59.0% | 100 |
| Apr 22SEC | Jorey Chernett10% Owner | Buy | 100,0009,878,988 held (+1%) | $1.58 | $158K | +34.8% | 100 |
| Apr 22SEC | Jorey Chernett10% Owner | Buy | 100,0009,978,988 held (+1%) | $1.51 | $151K | +41.1% | 100 |
| Mar 30SEC | Jorey Chernett10% Owner | Buy | 500,0009,393,276 held (+6%) | $1.35 | $675K | +57.8% | 100 |
| Mar 30SEC | Jorey Chernett10% Owner | Buy | 385,4429,778,988 held (+4%) | $1.25 | $482K | +70.4% | 100 |
| Mar 27SEC | Jorey Chernett10% Owner | Buy | 125,0008,868,276 held (+1%) | $1.40 | $175K | +52.1% | 100 |
| Mar 27SEC | Jorey Chernett10% Owner | Buy | 25,0008,893,276 held (+0%) | $1.44 | $36K | +47.9% | 100 |
| Mar 24SEC | Keith J SullivanFormer Officer & Director | Sell | 46,2891,590,924 held (−3%) | $1.34 | $62K | +59.0% | — |
| Mar 24SEC | Steven PfanstielCFO | Sell | 16,431828,781 held (−2%) | $1.34 | $22K | +59.0% | — |
| Mar 24SEC | William Andrew MacanGeneral Counsel | Sell | 16,005897,270 held (−2%) | $1.34 | $21K | +59.0% | — |
| Mar 23SEC | Jorey Chernett10% Owner | Buy | 169,4728,743,276 held (+2%) | $1.41 | $239K | +51.1% | 100 |
| Mar 20SEC | Jorey Chernett10% Owner | Buy | 607,4008,123,804 held (+8%) | $1.35 | $820K | +57.8% | 100 |
| Mar 20SEC | Jorey Chernett10% Owner | Buy | 450,0008,573,804 held (+6%) | $1.33 | $598K | +60.2% | 100 |
| Mar 18SEC | Jorey Chernett10% Owner | Buy | 531,0007,516,404 held (+8%) | $1.16 | $616K | +83.6% | 100 |
| Mar 6SEC | William Andrew MacanGeneral Counsel | Sell | 609879,525 held (−0%) | $1.34 | $816 | +59.0% | — |
| Feb 27SEC | Keith J SullivanCEO, President | Sell | 8,4521,524,713 held (−1%) | $1.35 | $11K | +57.8% | — |
| Feb 27SEC | William Andrew MacanGeneral Counsel | Sell | 3,427880,134 held (−0%) | $1.35 | $5K | +57.8% | — |
| Feb 18SEC | Keith J SullivanCEO, President | Sell | 33,8471,533,165 held (−2%) | $1.65 | $56K | +29.1% | — |
| Feb 18SEC | William Andrew MacanGeneral Counsel | Sell | 14,120673,561 held (−2%) | $1.65 | $23K | +29.1% | — |
| Feb 12SEC | Keith J SullivanCEO, President | Sell | 40,9761,567,012 held (−3%) | $1.55 | $64K | +37.4% | — |
| Feb 12SEC | William Andrew MacanGeneral Counsel | Sell | 3,485687,681 held (−1%) | $1.55 | $5K | +37.4% | — |
Insiders at Neuronetics, Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Jorey Chernett10% Owner | $4.8M | — | Aug 17, 2026 | 100 |
| Keith J SullivanFormer Officer & Director | — | $193K | Mar 24, 2026 | — |
| William Andrew MacanGeneral Counsel | — | $56K | Mar 24, 2026 | — |
| Steven PfanstielCFO | — | $34K | May 21, 2026 | — |
Insider activity at other Health Care companies
Same sector, ranked by insider buying in the last 90 days.
STIM stock: common questions
Are Neuronetics, Inc. insiders buying STIM stock?
In the past 12 months, 1 insiders reported open-market purchases of STIM worth $4.8M. The latest was 10% Owner Jorey Chernett bought $44K of STIM at $3.16.
Are Neuronetics, Inc. insiders selling STIM stock?
3 insiders reported sales worth $282K over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is STIM's 52-week range?
Over the past year STIM has traded between $1.18 and $3.30. It last closed at $2.13 on Oct 9, 2026.